Published Date : 2024-Jul-22
Interventional oncology is a rapidly growing field within cancer treatment, focusing on minimally invasive procedures to diagnose and treat cancer. These procedures are guided by imaging techniques and involve the use of specialized devices to target tumors directly, offering an alternative to traditional surgery and radiation therapy. Here, we highlight the top 10 companies leading the interventional oncology devices market, driving innovation and improving patient outcomes.
Intellectual Market Insights Research
Interventional Oncology Devices Market Size, Share & Trends Analysis Report By Product, By Procedure, By Cancer Type, By End Users, and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America), Growth Potential, Price Trends, Competitive Market Share & Forecast Till 2028.
Global Interventional Oncology Devices Market size was valued at USD 2.25 Billion in 2021 and is projected to reach USD 3.59 Billion by 2028, growing at a CAGR of 6.6% from 2021 to 2028 according to a new report by Intellectual Market Insights Research.
The Interventional Oncology Devices market research report comprises a thorough examination of the current and future scenario of this industry vertical. The research highlights major trends and opportunities, as well as challenges, for various segments and sub-segments, while broadening the company horizon. The study report also includes extensive information based on past and present patterns across several industry verticals to help find various expansion prospects. Throughout the forecast period, several estimations regarding market share, market size, and industry growth rate are presented. The research includes information on competitive analysis as well as consumption habits and pricing strategies depending on the Interventional Oncology Devices market.
Get Insights: https://www.intellectualmarketinsights.com/report/interventional-oncology-devices-market-size/imi-000785
Minimally invasive techniques are becoming increasingly popular due to their reduced recovery times, lower risk of complications, and effectiveness in targeting tumors.
Advancements in imaging technologies, such as CT, MRI, and ultrasound, are enhancing the precision and efficacy of interventional oncology procedures.
There is a growing emphasis on personalized medicine, where treatments are tailored to the specific genetic and molecular profile of the patient’s tumor.
Combining interventional oncology with other treatment modalities, such as immunotherapy and chemotherapy, is becoming a common approach to enhance treatment effectiveness.
Industry: Medical Device Company
Overview: Boston Scientific Corporation (BSC), headquartered in Watertown, Massachusetts, United States and was founded in 1979. The company is a global leader in medical devices, offering a comprehensive range of interventional oncology products designed to improve patient outcomes.
Key Products:
Radiofrequency Ablation (RFA) Systems: For precise tumor ablation.
Transarterial Chemoembolization (TACE) Devices: Combining chemotherapy and embolization to treat liver cancer.
Innovations:
Development of advanced imaging-guided ablation systems.
Integration of AI for enhanced treatment planning and monitoring.
Industry: Medical Device Company
Overview: Medtronic plc is an Irish medical device company. The company was founded in 1949 and its operational and executive headquarters are in Minneapolis, Minnesota, United States & its legal headquarters are in Dublin, Ireland. The company is a leading medical technology company, offering a wide range of devices for various interventional procedures, including oncology.
Key Products:
Microwave Ablation Systems: For treating liver, lung, and kidney tumors.
Cryoablation Systems: Utilizing extreme cold to destroy cancer cells.
Innovations:
Development of minimally invasive, image-guided ablation technologies.
Integration of advanced imaging and navigation systems.
Industry: Medical Equipment Manufacture Company
Overview: AngioDynamics is medical equipment manufacture company. Headquartered in Queensbury, New York, United States and was founded in 1988. The company specializes in minimally invasive medical devices, offering a broad portfolio of interventional oncology products.
Key Products:
NanoKnife System: Utilizing irreversible electroporation (IRE) for tumor ablation.
Embolization Products: For targeted tumor therapy.
Innovations:
Pioneering IRE technology for non-thermal tumor ablation.
Advanced embolization techniques for precise treatment.
Industry: Healthcare
Overview: BTG International Ltd. is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer and other disorders. Headquartered in London, United Kingdom and was founded in 1991. British Technology Group, now a part of Boston Scientific, was a leading provider of interventional medicine products, with a strong focus on oncology.
Key Products:
SIR-Spheres Y-90 Resin Microspheres: For selective internal radiation therapy (SIRT).
DC Bead LUMI: Drug-eluting beads for localized chemotherapy delivery.
Innovations:
Development of targeted radiotherapy and drug delivery systems.
Focus on precision medicine and personalized treatments.
Industry: Healthcare
Overview: Merit Medical was Founded in 1987 and headquarters in South Jordan, Utah, United States that is a leading manufacturer and marketer of proprietary disposable medical device. The company offers a diverse range of products for interventional oncology, focusing on improving patient care and outcomes.
Key Products:
Embosphere Microspheres: For embolization therapy.
StarBurst RFA Devices: For tumor ablation.
Innovations:
Development of advanced embolization and ablation technologies.
Integration of imaging and navigation systems for precise treatment.
Industry: Manufacturing of Medical Devices
Overview: Cook Medical is an American privately held company based in Bloomington, Indiana, USA and was founded in 1963. The company is a global leader in medical device manufacturing, offering a wide range of interventional oncology products.
Key Products:
EchoTip ProCore Endobronchial Ultrasound Needles: For precise tissue sampling.
Beacon Tip Angiographic Catheters: For targeted tumor therapy.
Innovations:
Development of high-precision biopsy and ablation devices.
Focus on enhancing imaging-guided interventional procedures.
Industry: Medical Equipment Manufacture Company
Overview: Sirtex Medical Limited is a medical device company, providing radioactive treatment for inoperable liver cancer called SIR-Spheres microspheres. Sirtex was established in 1997 in Australia and currently maintains offices and manufacturing facilities in the U.S., Australia, Germany, and Singapore. The company specializes in targeted radiation therapy for cancer treatment, with a focus on liver tumors.
Key Products:
SIR-Spheres Y-90 Resin Microspheres: For selective internal radiation therapy (SIRT).
Innovations:
Development of targeted radiotherapy solutions for liver cancer.
Focus on precision medicine and improving patient outcomes.
Industry: Healthcare Services
Overview: Siemens Healthineers is a German company, founded in 2017 and headquarters in Erlangen, Germany. The company is a global leader in medical technology, offering advanced imaging and therapy solutions for interventional oncology.
Key Products:
ARTIS Pheno: An advanced interventional imaging system.
MOBILETT Elara Max: A mobile X-ray system for precise imaging.
Innovations:
Development of cutting-edge imaging technologies for enhanced treatment planning and execution.
Integration of AI and machine learning for personalized treatment.
Industry: Medical Equipment Manufacturing
Overview: Terumo Corporation was founded in 1921 in Tokyo, Japan. The company is a leading medical device manufacturer, offering a range of interventional oncology products.
Key Products:
QuiremSpheres: Holmium-based microspheres for radioembolization.
Embolization Products: For targeted tumor therapy.
Innovations:
Development of innovative radioembolization solutions.
Focus on improving patient outcomes with minimally invasive therapies.
Overview: Surgical Systems and Instruments Manufacturer
Overview: Ethicon is a subsidiary of Johnson & Johnson , offers a range of surgical and interventional products, including those for oncology. The Company was founded in 1915 (Edinburgh, Scotland) and headquartered in Raritan, New Jersey, United States.
Key Products:
Neuwave Microwave Ablation System: For precise tumor ablation.
Advanced Bipolar Energy Devices: For tissue sealing and cutting.
Innovations:
Development of advanced ablation and energy-based devices.
Focus on minimally invasive techniques for cancer treatment.
By Product
By Procedure
By Cancer Type
By End Users
The interventional oncology devices market is rapidly evolving, driven by advancements in technology and a growing demand for minimally invasive cancer treatments. Leading companies like Boston Scientific, Medtronic, AngioDynamics, BTG, Merit Medical Systems, Cook Medical, Sirtex Medical, Siemens Healthineers, Terumo Corporation, and Johnson & Johnson (Ethicon) are at the forefront of this transformation, offering innovative solutions that improve patient outcomes and enhance the precision of cancer treatments.
Intellectual Market Insights Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, Aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.
IMIR has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Follow Us: LinkedIn
Mr. Smit Patel
Phone: +1 (814) 487 8486
Email: smit@intellectualmarketinsights.com
Corporate Sales: sales@intellectualmarketinsights.com
